Cargando…
Ephrin (Eph) receptor and downstream signaling pathways: a promising potential targeted therapy for COVID‑19 and associated cancers and diseases
Autores principales: | Zalpoor, Hamidreza, Akbari, Abdullatif, Nabi-Afjadi, Mohsen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977187/ https://www.ncbi.nlm.nih.gov/pubmed/35377105 http://dx.doi.org/10.1007/s13577-022-00697-2 |
Ejemplares similares
-
The roles of metabolic profiles and intracellular signaling pathways of tumor microenvironment cells in angiogenesis of solid tumors
por: Zalpoor, Hamidreza, et al.
Publicado: (2022) -
Lectins and lectibodies: potential promising antiviral agents
por: Nabi-Afjadi, Mohsen, et al.
Publicado: (2022) -
The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies
por: Zalpoor, Hamidreza, et al.
Publicado: (2022) -
Hypoxia‐inducible factor 1 alpha (HIF‐1α) stimulated and P2X7 receptor activated by COVID-19, as a potential therapeutic target and risk factor for epilepsy
por: Zalpoor, Hamidreza, et al.
Publicado: (2022) -
Eph receptors and ephrins as targets for cancer therapy
por: Xi, Hong-Qing, et al.
Publicado: (2012)